Product Information
CETIRIZINE HCL 1 MG/ML SOLN is a generic product labeled by Chartwell RX LLC, priced at $0.3318 per ML under NDC 62135005747. Its NADAC has been published 92 times since Oct 12, 2022.
FDA first approved this application on May 11, 2012. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
Chartwell RX LLCNDC
62135005747
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078876FDA Approved
5/11/2012
TE Code
AA
On Market Since
5/11/2012
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 1 MG/ML SOLN has been published 92 times since Oct 12, 2022, and over the history we have for it it has risen 1792.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3318 per ML |
|---|---|
| All-time high | $0.3381 (Jan 14, 2026) |
| All-time low | $0.0175 (Oct 12, 2022) |
| 52-week high | $0.3381 |
| 52-week low | $0.3127 |
| Median price | $0.3245 |
| Average price | $0.2294 |
| Largest weekly change | +1620.9% (Jul 23, 2025) |
| Weeks tracked | 92 |
| Tracking since | Oct 12, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cetirizine Hydrochloride Oral Solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 1 MG/ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 1 MG/ML SOLN, manufactured by Chartwell RX LLC, is $0.3318 per ML (NDC 62135005747), effective Sep 30, 2026.
How has the price of CETIRIZINE HCL 1 MG/ML SOLN changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 1 MG/ML SOLN has risen 1792.8%. It has been tracked across 92 weekly CMS publications since Oct 12, 2022.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 1 MG/ML SOLN?
Since Oct 12, 2022, the NADAC for CETIRIZINE HCL 1 MG/ML SOLN has ranged from a low of $0.0175 (Oct 12, 2022) to a high of $0.3381 (Jan 14, 2026), with a median of $0.3245 per ML.
Are there cheaper alternatives to CETIRIZINE HCL 1 MG/ML SOLN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CETIRIZINE HCL 1 MG/ML SOLN, is $0.0223 per ML — about 93% below CETIRIZINE HCL 1 MG/ML SOLN.
Who manufactures CETIRIZINE HCL 1 MG/ML SOLN?
CETIRIZINE HCL 1 MG/ML SOLN (NDC 62135005747) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.